‘It’s Time For The Biosimilar Program To Evolve‘ – Biosimilars Forum’s Reed Sees Need For Change
Streamlining, Interchangeability, PBMs, And OTBB Signatory Authority
Julie Reed speaks to Generics Bulletin about the US biosimilars market (Biosimilars Forum) 
